Radnor Capital Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,000
| Closed | -$87K | – | 245 |
|
|
2022
Q1 | $87K | Hold |
10,000
| – | – | 0.02% | 237 |
|
|
2021
Q4 | $160K | Hold |
10,000
| – | – | 0.04% | 240 |
|
|
2021
Q3 | $184K | Hold |
10,000
| – | – | 0.11% | 89 |
|
|
2021
Q2 | $140K | Hold |
10,000
| – | – | 0.05% | 190 |
|
|
2021
Q1 | $147K | Hold |
10,000
| – | – | 0.05% | 203 |
|
|
2020
Q4 | $194K | Hold |
10,000
| – | – | 0.05% | 189 |
|
|
2020
Q3 | $112K | Hold |
10,000
| – | – | 0.04% | 186 |
|
|
2020
Q2 | $133K | Buy |
+10,000
| New | +$133K | 0.05% | 174 |
|